CBT-295

Revisión del cliente

Based on 1 Customer Validation

CBT-295 is an orally active autotaxin (ATX) inhibitor. CBT-295 exhibits a significant reduction in inflammatory cytokines like TGF-β, TNF-α and IL-6 levels, also reduced bile duct proliferation marker CK-19 and lowered liver fibrosis. The reversal of liver fibrosis with CBT-295 led to a reduction in blood and brain ammonia levels. CBT-295 also reduced neuroinflammation induced by ammonia. CBT-295 is promising for research of liver cirrhosis and associated encephalopathy.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.34%
  • No. CAS: 1623794-90-0
  • Fòrmula: C18H20ClN3O
  • Peso molecular:329.82
  • Almacenamiento:

    4°C, sealed storage, away from moisture and light

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Ver todos los productos específicos de isoformas TGF-beta/Smad

More

Ver todos los productos específicos de isoformas Interleukin Related

More
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00